sprite-preloader
Anzeige
Mehr »
Samstag, 21.10.2017 Börsentäglich über 12.000 News von 567 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: A2APN2 ISIN: US23725P1003 Ticker-Symbol: LS1N 
Aktie:
Branche
Medien
Aktienmarkt
Sonstige
1-Jahres-Chart
DARIOHEALTH CORP Chart 1 Jahr
1-Woche-Intraday-Chart
DARIOHEALTH CORP 1-Woche-Intraday-Chart
11.08.2017 | 22:21
(8 Leser)
Schrift ändern:
(0 Bewertungen)

ACCESSWIRE·Mehr Nachrichten von ACCESSWIRE

CAESAREA, ISRAEL / ACCESSWIRE / August 11, 2017 / DarioHealth Corp. (NASDAQ: DRIO) will host a conference call and live webcast to discuss the results of second quarter 2017, to be held Monday, August 14, 2017, at 9:00 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

  • Date, Time: August 14, 2017, at 9:00 AM ET
  • Toll Free: 888-567-1603
  • International: 862-255-5347
  • Live Webcast: http://www.investorcalendar.com/event/19824

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on August 28, 2017.

  • Toll Free: 877-481-4010
  • International: 919-882-2331
  • Replay ID#: 19824
  • Webcast: www.investorcalendar.com

About DarioHealth Corp.

DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more information, visit http://mydario.investorroom.com/.

SOURCE: Investor Network


© 2017 ACCESSWIRE